Loading...
Loading...
Among the 4 tracked institutional investors we monitor, NRXP (NRX PHARMACEUTICALS INC) is held with a combined value of $2.43M across 940,521 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.98M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$2.43M
Total Shares Held
940,521
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.98M | 0.00% | New |
| 2 | BlackRock, Inc. | $210.86K | 0.00% | +19.8% |
| 3 | STATE STREET CORP | $185.28K | 0.00% | - |
| 4 | CITADEL ADVISORS LLC | $52.61K | 0.00% | -31.0% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of NRXP with a position worth $1.98M, representing 0.00% of their portfolio. In total, 4 institutional investors hold NRXP with a combined value of $2.43M.
In the most recent quarter, 1 fund opened a new position in NRXP. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $2.43M worth of NRXP stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $1.98M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For NRXP, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their NRXP positions.